Teva
Executive Summary
Receives FDA approval on July 31 for the first generic version of Merck's Dolobid (diflunisal) tablets, a non-steroidal antiinflammatory agent. Teva's Lemmon subsidiary will market the generic non-steroidal antiinflammatory agent in the U.S....